Drug Safety Panel Urges New Entity To Oversee Japan Drug Approvals

TOKYO - An ad hoc study commission debating prevention of recurring drug-induced hepatitis and HIV infections has recommended creating an independent entity that would supervise pharmaceutical approvals, drug safety and adverse events in an effort to toughen Japanese new drug approval processes